BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22617735)

  • 1. Effectiveness and cost-effectiveness of supplemental glutamine dipeptide in total parenteral nutrition therapy for critically ill patients: a discrete event simulation model based on Italian data.
    Pradelli L; Iannazzo S; Zaniolo O; Muscaritoli M; Eandi M
    Int J Technol Assess Health Care; 2012 Jan; 28(1):22-8. PubMed ID: 22617735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients.
    Pradelli L; Povero M; Muscaritoli M; Eandi M
    Eur J Clin Nutr; 2015 May; 69(5):546-51. PubMed ID: 25469466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model.
    Pradelli L; Eandi M; Povero M; Mayer K; Muscaritoli M; Heller AR; Fries-Schaffner E
    Clin Nutr; 2014 Oct; 33(5):785-92. PubMed ID: 24345520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study.
    Déchelotte P; Hasselmann M; Cynober L; Allaouchiche B; Coëffier M; Hecketsweiler B; Merle V; Mazerolles M; Samba D; Guillou YM; Petit J; Mansoor O; Colas G; Cohendy R; Barnoud D; Czernichow P; Bleichner G
    Crit Care Med; 2006 Mar; 34(3):598-604. PubMed ID: 16505644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients.
    Grau T; Bonet A; Miñambres E; Piñeiro L; Irles JA; Robles A; Acosta J; Herrero I; Palacios V; Lopez J; Blesa A; Martínez P;
    Crit Care Med; 2011 Jun; 39(6):1263-8. PubMed ID: 21336131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials.
    Stehle P; Ellger B; Kojic D; Feuersenger A; Schneid C; Stover J; Scheiner D; Westphal M
    Clin Nutr ESPEN; 2017 Feb; 17():75-85. PubMed ID: 28361751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost containment through L-alanyl-L-glutamine supplemented total parenteral nutrition after major abdominal surgery: a prospective randomized double-blind controlled study.
    Mertes N; Schulzki C; Goeters C; Winde G; Benzing S; Kuhn KS; Van Aken H; Stehle P; Fürst P
    Clin Nutr; 2000 Dec; 19(6):395-401. PubMed ID: 11104589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis.
    Pradelli L; Klek S; Mayer K; Omar Alsaleh AJ; Rosenthal MD; Heller AR; Muscaritoli M
    Crit Care; 2020 Nov; 24(1):634. PubMed ID: 33143750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study.
    Pytlík R; Benes P; Patorková M; Chocenská E; Gregora E; Procházka B; Kozák T
    Bone Marrow Transplant; 2002 Dec; 30(12):953-61. PubMed ID: 12476290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What happened to total parenteral nutrition? The disappearance of its use in a trauma intensive care unit.
    Rhee P; Hadjizacharia P; Trankiem C; Chan L; Salim A; Brown C; Green D; Inaba K; Law J; Demetriades D
    J Trauma; 2007 Dec; 63(6):1215-22. PubMed ID: 18212641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glutamine-supplemented parenteral nutrition on mortality in critically ill patients.
    Sacks GS
    Nutr Clin Pract; 2011 Feb; 26(1):44-7. PubMed ID: 21266696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of Omega-3 supplementation in critically ill patients with sepsis.
    Kyeremanteng K; Shen J; Thavorn K; Fernando SM; Herritt B; Chaudhuri D; Tanuseputro P
    Clin Nutr ESPEN; 2018 Jun; 25():63-67. PubMed ID: 29779820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition.
    Griffiths RD; Jones C; Palmer TE
    Nutrition; 1997 Apr; 13(4):295-302. PubMed ID: 9178278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
    Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
    Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evidence for a medical nutrition therapy protocol: enteral feedings for critically ill patients.
    Kattelmann KK; Hise M; Russell M; Charney P; Stokes M; Compher C
    J Am Diet Assoc; 2006 Aug; 106(8):1226-41. PubMed ID: 16863719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials.
    Wang Y; Jiang ZM; Nolan MT; Jiang H; Han HR; Yu K; Li HL; Jie B; Liang XK
    JPEN J Parenter Enteral Nutr; 2010; 34(5):521-9. PubMed ID: 20852180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
    Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
    Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone administration during nutritional support: what is to be gained?
    Ziegler TR
    New Horiz; 1994 May; 2(2):244-56. PubMed ID: 7922450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a multiple-site intensive care unit telemedicine program on clinical and economic outcomes: an alternative paradigm for intensivist staffing.
    Breslow MJ; Rosenfeld BA; Doerfler M; Burke G; Yates G; Stone DJ; Tomaszewicz P; Hochman R; Plocher DW
    Crit Care Med; 2004 Jan; 32(1):31-8. PubMed ID: 14707557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.